- Johnson & Johnson (NYSE:JNJ) will be responsible for all talc-related claims in the US and Canada and will "indemnify" soon-to-be spun off Kenvue (KVUE) consumer health unit for any costs.
- "Johnson & Johnson (JNJ) has agreed to retain all the talc-related liabilities -- and indemnify Kenvue (KVUE) for any and all costs -- arising from litigation in the United States and Canada. Any suggestion to the contrary is false and misleading," Erik Haas, the healthcare giant's vice president of litigation, told Reuters.
- The Financial Times has reported that since the beginning of April, at least seven talc-related lawsuits has named Kenvue (KVUE).
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.